Literature DB >> 33752297

Impact of the UK COVID-19 pandemic on HbA1c testing and its implications for diabetes diagnosis and management.

David Holland1, Adrian H Heald2,3, Mike Stedman4, Lewis Green5, Jonathan Scargill6, Christopher J Duff7,8, Fahmy W F Hanna9,10, Pensee Wu7,11, Ian Halsall12, Neil Gaskell13, Anthony A Fryer7,8.   

Abstract

Entities:  

Year:  2021        PMID： 33752297     DOI： 10.1111/ijcp.13980

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN： 1368-5031            Impact factor:   2.503


× No keyword cloud information.
  5 in total

1.  Improved glucometrics in people with type 1 diabetes 1 year into the COVID-19 pandemic.

Authors:  Namam Ali; Soumia El Hamdaoui; Giesje Nefs; Cornelis J Tack; Bastiaan E De Galan
Journal:  BMJ Open Diabetes Res Care       Date:  2022-05

2.  Trends in lifetime risk and years of potential life lost from diabetes in the United States, 1997-2018.

Authors:  Alain K Koyama; Yiling J Cheng; Ralph Brinks; Hui Xie; Edward W Gregg; Annika Hoyer; Meda E Pavkov; Giuseppina Imperatore
Journal:  PLoS One       Date:  2022-05-24       Impact factor: 3.752

3.  People with Type 2 Diabetes Mellitus (T2DM) Self-Reported Views on Their Own Condition Management Reveal a High Level of Insight into the Challenges Faced.

Authors:  Mike Stedman; Rustam Rea; Mark Livingston; Katie McLoughlin; Louise Wong; Stephen Brown; Katherine Grady; Roger Gadsby; Angela Paisley; Adrian Heald
Journal:  J Diabetes Sci Technol       Date:  2021-05-17

4.  Assessment of the effect of the COVID-19 pandemic on UK HbA1c testing: implications for diabetes management and diagnosis.

Authors:  David Holland; Adrian H Heald; Mike Stedman; Fahmy Hanna; Pensee Wu; Christopher Duff; Lewis Green; Sarah Robinson; Ian Halsall; Neil Gaskell; John Pemberton; Christine Bloor; Anthony A Fryer
Journal:  J Clin Pathol       Date:  2021-10-13       Impact factor: 3.411

Review 5.  Diabetes and tuberculosis: a syndemic complicated by COVID-19.

Authors:  Violeta Antonio-Arques; Josep Franch-Nadal; Joan A Caylà
Journal:  Med Clin (Barc)       Date:  2021-05-06       Impact factor: 1.725
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.